Company Profile
live
SmallMicroneedle Solutions Ltd
13967922•Private Limited With Share Capital
Nexus Discovery Way, University Of Leeds, Leeds, LS23AA
Get Full Access
Incorporated
10/03/2022
Company Age
4 years
Directors
7
Employees
4
SIC Code
32500
Risk
low risk
Company Overview
Registration, classification & business activity
Microneedle Solutions Ltd (13967922) is a private limited with share capital incorporated on 10/03/2022 (4 years old) and registered in leeds, LS23AA. The company operates under SIC code 32500 - manufacture of medical and dental instruments and supplies.
Private Limited With Share Capital
SIC: 32500
Small
Incorporated 10/03/2022
LS23AA
4 employees
Financial Overview
Total Assets
£1.45M
Liabilities
£51.8K
Net Assets
£1.40M
Est. Turnover
£470.0K
AI Estimated
Unreported
Cash
£1.31M
Key Metrics
4
Employees
7
Directors
28
Shareholders
7
Patents
Board of Directors
5
Name
Position
director
director
director
director
director
Filed Documents
38
Document Name
Category
Date
Resolution
Category:Resolution
Date:16-09-2026
Replacement Filing Of Confirmation Statement With Made Up Date
Category:Confirmation Statement
Date:21-08-2026
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:13-07-2026
Confirmation Statement With Updates
Category:Confirmation Statement
Date:22-06-2026
Appoint Person Director Company With Name Date
Category:Officers
Date:11-05-2026
Appoint Person Director Company With Name Date
Category:Officers
Date:10-12-2025
Capital Allotment Shares
Category:Capital
Date:02-12-2025
Resolution
Category:Resolution
Date:02-12-2025
Memorandum Articles
Category:Incorporation
Date:02-12-2025
Appoint Person Director Company With Name Date
Category:Officers
Date:28-11-2025
Termination Director Company With Name Termination Date
Category:Officers
Date:27-11-2025
Confirmation Statement With Updates
Category:Confirmation Statement
Date:20-06-2025
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:06-05-2025
Confirmation Statement With Updates
Category:Confirmation Statement
Date:16-07-2024
Change Person Director Company With Change Date
Category:Officers
Date:09-07-2024
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:08-07-2024
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:13-06-2024
Appoint Person Director Company With Name Date
Category:Officers
Date:29-04-2024
Capital Allotment Shares
Category:Capital
Date:28-02-2024
Resolution
Category:Resolution
Date:09-02-2024
Appoint Person Director Company With Name Date
Category:Officers
Date:12-12-2023
Capital Alter Shares Subdivision
Category:Capital
Date:15-11-2023
Capital Allotment Shares
Category:Capital
Date:15-11-2023
Memorandum Articles
Category:Incorporation
Date:15-11-2023
Resolution
Category:Resolution
Date:15-11-2023
Change Person Director Company With Change Date
Category:Officers
Date:03-10-2023
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:03-10-2023
Change Person Director Company With Change Date
Category:Officers
Date:03-10-2023
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:03-10-2023
Accounts With Accounts Type Dormant
Category:Accounts
Date:03-10-2023
Change Person Director Company With Change Date
Category:Officers
Date:06-07-2023
Confirmation Statement With Updates
Category:Confirmation Statement
Date:14-06-2023
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:10-03-2023
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:10-03-2023
Change Person Director Company With Change Date
Category:Officers
Date:10-03-2023
Change Person Director Company With Change Date
Category:Officers
Date:10-03-2023
Confirmation Statement With Updates
Category:Confirmation Statement
Date:10-03-2023
Incorporation Company
Category:Incorporation
Date:10-03-2022
Innovate Grants
2
This company received a grant of £55305.67 for Lnp-Mrna Vaccine Patch In Vivo Immunisation Study. The project started on 01/08/2024 and ended on 31/01/2025.
This company received a grant of £471454.0 for First In Human Clinical Trial To Assess The Safety Of Mns'S Microneedle Platform. The project started on 01/01/2026 and ended on 31/12/2026.
Import / Export
Imports
12 Months0
60 Months1
Exports
12 Months0
60 Months0
Risk Assessment
low risk
International Score
Future Factor
excellent
Performance Rating
Accounts
Typetotal exemption full
Due Date31/12/2027
Filing Date13/07/2026
Latest Accounts31/03/2026
Trading Addresses
Nexus Discovery Way, University Of Leeds, Leeds, Ls2 3Aa, LS23AARegistered
Related Companies
10
Contact
Nexus Discovery Way, University Of Leeds, Leeds, LS23AA